<DOC>
	<DOCNO>NCT02226302</DOCNO>
	<brief_summary>The objective develop organotypic model assess effect obesity expression methylation status estrogen-responsive gene endometrial cancer . Omental fat sample remove participant surgery fat sample use laboratory analysis .</brief_summary>
	<brief_title>Linking Obesity Estrogen-responsive Genes Endometrial Cancer</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Age 1880 year Any patient abdominal surgery ( Laparoscopic open technique ) benign condition Eastern Cooperative Oncology Group ( ECOG ) performance status 02 Patients must adequate : Hematologic function : Neutrophils ≥ 1.5 x 109/L platelet ≥ 100 x 109/L Renal function : serum creatinine ≤ ULN estimate glomerular filtration rate ( eGFR ) [ CKDEPI Formula ] ≥ 60 mL/min Hepatic function : serum bilirubin ≤ 1.5 x ULN AST ≤ 2.5 x ULN ALT≤ 2.5 x ULN Physically able undergo surgery Written inform consent Confirmed gynaecological malignancy Contraindications and/or unfit Surgery : serious concomitant systemic disorder incompatible study ( discretion investigator ) ; Patients pregnant lactate Serious illness medical condition limit , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia ( patient stable AF eligible ) , psychiatric illness/social situation would limit compliance study requirement . Patients disseminate intraperitoneal malignancy suspect ovarian cancer HIV positive Previous bariatric surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Endometrial cancer</keyword>
	<keyword>Obesity</keyword>
</DOC>